Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Invasive Candidiasis in Liver Transplant Recipients: A Review

Invasive Candidiasis in Liver Transplant Recipients: A Review Purpose of ReviewThis review summarizes the literature on invasive candidiasis (IC) in liver transplant recipients (LTRs) regarding diagnostic strategies, treatment, and prophylaxis.Recent FindingsRecent literature on IC has expanded and refined definitions of risk factors for IC in LTRs. We discuss increasing rates of resistance among candida species and new antifungals. Diagnostic modalities continue to decrease time to initiation of empiric antifungals, which may impact outcomes.SummaryA well-documented host of risk factors for IC may allow for targeted prophylaxis, while minimizing exposure to antifungal medications. Further research on minimum effective duration of treatment and prophylaxis is needed to combat resistance. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Fungal Infection Reports Springer Journals

Invasive Candidiasis in Liver Transplant Recipients: A Review

Loading next page...
 
/lp/springer-journals/invasive-candidiasis-in-liver-transplant-recipients-a-review-k3nFYTdGvw

References (82)

Publisher
Springer Journals
Copyright
Copyright © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021
ISSN
1936-3761
eISSN
1936-377X
DOI
10.1007/s12281-021-00426-6
Publisher site
See Article on Publisher Site

Abstract

Purpose of ReviewThis review summarizes the literature on invasive candidiasis (IC) in liver transplant recipients (LTRs) regarding diagnostic strategies, treatment, and prophylaxis.Recent FindingsRecent literature on IC has expanded and refined definitions of risk factors for IC in LTRs. We discuss increasing rates of resistance among candida species and new antifungals. Diagnostic modalities continue to decrease time to initiation of empiric antifungals, which may impact outcomes.SummaryA well-documented host of risk factors for IC may allow for targeted prophylaxis, while minimizing exposure to antifungal medications. Further research on minimum effective duration of treatment and prophylaxis is needed to combat resistance.

Journal

Current Fungal Infection ReportsSpringer Journals

Published: Dec 1, 2021

Keywords: Liver transplant; Candida; Infection; Solid organ transplant; Invasive fungal infection; Fluconazole

There are no references for this article.